Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $32,659 - $50,859
-24,931 Reduced 98.47%
388 $0
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $36,592 - $74,446
25,236 Added 30404.82%
25,319 $38,000
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $167 - $269
83 New
83 $0
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $50,636 - $102,830
-38,951 Reduced 44.49%
48,596 $94,000
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $205,735 - $303,788
87,547 New
87,547 $215,000
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $1.03 Million - $2.02 Million
-351,863 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$4.98 - $6.63 $287,176 - $382,325
-57,666 Reduced 14.08%
351,863 $1.85 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $917,880 - $1.97 Million
358,547 Added 703.28%
409,529 $2.25 Million
Q1 2021

May 17, 2021

SELL
$2.69 - $5.25 $182,236 - $355,666
-67,746 Reduced 57.06%
50,982 $139,000
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $186,079 - $263,563
-58,700 Reduced 33.08%
118,728 $378,000
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $471,996 - $823,617
158,388 Added 831.87%
177,428 $710,000
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $10,396 - $19,249
4,540 Added 31.31%
19,040 $75,000
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $27,840 - $63,654
14,500 New
14,500 $36,000
Q3 2019

Nov 14, 2019

SELL
$2.17 - $3.14 $45,559 - $65,924
-20,995 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $3,152 - $3,787
1,246 Added 6.31%
20,995 $63,000
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $49,569 - $73,663
19,749 New
19,749 $59,000
Q4 2018

Feb 14, 2019

SELL
$1.59 - $2.66 $34,983 - $58,525
-22,002 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$1.59 - $2.42 $21,259 - $32,357
-13,371 Reduced 37.8%
22,002 $47,000
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $79,942 - $164,484
35,373 New
35,373 $80,000
Q1 2018

May 15, 2018

SELL
$3.51 - $6.04 $38,311 - $65,926
-10,915 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$3.26 - $4.78 $63,807 - $93,558
-19,573 Reduced 64.2%
10,915 $36,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $106,098 - $135,366
30,488
30,488 $134,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.